2015 Medical Evaluation Policy 
Canna Law Blog
OCTOBER 12, 2022
Based upon it’s “scientific and medical evaluation”, the FDA found marijuana supremely dangerous and formally recommended that the plant remain in schedule I. Fundamentally, however, things are no different than in 2015. First, HHS and FDA undertook this very review, to less fanfare, only seven years ago.
Cannabis Law Report
MARCH 25, 2019
Both paths are complex processes in which scientific, medical, policy and political forces have influence. The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). 1] professionals.
Expert insights. Personalized for you.
93 
Let's personalize your content